School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Kent St, Bentley, WA, 6102, Australia.
Gold Coast Health, Gold Coast, QLD, 4215, Australia.
Int J Clin Pharm. 2020 Apr;42(2):567-578. doi: 10.1007/s11096-020-01001-8. Epub 2020 Mar 12.
Background Australian government funding for Residential Medication Management Reviews and Home Medicines Reviews commenced in 1997 and 2001 respectively. Limited data are available on their provision in Australia. Objective To investigate the extent and characteristics of Home Medicines Review and Residential Medication Management Review services provided by accredited pharmacists practising in Western Australia. Setting Pharmacists in Western Australia accredited by the Australian Association of Consultant Pharmacy or Society of Hospital Pharmacists of Australia. Method A paper questionnaire was developed and sent to 198 accredited pharmacists in Western Australia in June 2017. Simple descriptive statistics summarised demographic information and other responses. Logistic regression evaluated factors associated with the frequency of provision of Home Medicines Reviews. Main outcome measure Frequency and factors influencing services provided. Results Of 102 (51.5%) questionnaires returned, 67 (65.7%) respondents were female. Many were aged between 31 and 40 years (53; 52.0%). Most were accredited by the Australian Association of Consultant Pharmacy (101; 99.0%) and mainly offered Home Medicines Reviews (70; 68.6%). Home Medicines Reviews provided over the previous 12 months were limited in frequency with one quarter providing either 1-10 (27; 26.5%) or 21-50 (28; 27.5%) reviews. The median "average" preparation, interview and report writing times, plus communication with other health professionals aggregated to 175.0 min (interquartile range: 140.0-235.0 min) for Home Medicine Reviews and 110.0 min (90.0-140.0) for Residential Medication Management Reviews. Pharmacists born overseas and those who were accredited for a longer time were associated with performing 51 or more Home Medicines Reviews annually. Only one-third (36/101; 35.6%) agreed the current payment was appropriate. Most agreed their Home Medicines Reviews (92/96; 95.8%) and Residential Medication Management Reviews (26/28; 92.9%) provided improved patient outcomes. Over 97% of accredited pharmacists intended to continue to remain accredited. Conclusions Wide variations were evident in the times taken for tasks associated with performing reviews. Most respondents considered their medication reviews contributed to improved patient outcomes. The wide variation in times taken for the reviews suggests a tiered structure for service provision, with appropriate payment within each tier, since most consider current remuneration inadequate.
澳大利亚政府分别于 1997 年和 2001 年开始为住院药物管理审查和家庭药物审查提供资金。关于其在澳大利亚的提供情况，数据有限。目的：调查在澳大利亚经认证的药剂师提供的家庭药物审查和住院药物管理审查服务的范围和特点。地点：西澳大利亚州经澳大利亚顾问药剂师协会或澳大利亚医院药剂师协会认证的药剂师。方法：2017 年 6 月，向西澳大利亚州的 198 名认证药剂师发放了纸质问卷。简单描述性统计数据总结了人口统计学信息和其他答复。逻辑回归评估了与提供家庭药物审查频率相关的因素。主要结果测量：服务提供的频率和影响因素。结果：在 102 份（51.5%）返回的问卷中，有 67 份（65.7%）的答卷来自女性。许多人年龄在 31 岁至 40 岁之间（53 岁；52.0%）。大多数人通过了澳大利亚顾问药剂师协会的认证（101 人；99.0%），主要提供家庭药物审查（70 人；68.6%）。在过去 12 个月中提供的家庭药物审查次数有限，四分之一的人提供了 1-10 次（27 人；26.5%）或 21-50 次（28 人；27.5%）审查。“平均”准备、访谈和报告撰写时间加上与其他卫生专业人员的沟通时间，总计为 175.0 分钟（四分位距：140.0-235.0 分钟），用于家庭药物审查和 110.0 分钟（90.0-140.0 分钟）用于住院药物管理审查。在海外出生的药剂师和认证时间较长的药剂师，每年进行 51 次或更多的家庭药物审查。只有三分之一（36/101；35.6%）的人认为目前的薪酬是合适的。大多数人同意他们的家庭药物审查（96/96；95.8%）和住院药物管理审查（28/28；92.9%）提高了患者的治疗效果。超过 97%的认证药剂师打算继续保持认证。结论：与审查相关的任务所花费的时间存在很大差异。大多数受访者认为他们的药物审查有助于改善患者的治疗效果。审查所花费的时间差异很大，表明服务提供存在分层结构，每层都有适当的报酬，因为大多数人认为目前的薪酬不足。
